Proteomics International Laboratories Secures Patent for OxiDx Technology in China

MT Newswires Live
2025/05/15

Proteomics International Laboratories' (ASX:PIQ) subsidiary, OxiDx, received an intellectual property patent in China for its platform technology designed to precisely measure levels of oxidative stress, according to a Thursday filing with the Australian bourse.

The patent is valid until 2039. Aside from China, OxiDx's technology has intellectual protection in the US, Japan, Europe, and Australia. The company's application for a second-generation patent is pending in the US, Singapore, and India, the filing stated.

The medical technology company's shares were up over 1% in recent Thursday trade.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10